Company: CRLBF
Filing Date: 2025-08-20
Form Type: SC TO-I
Source: 0001832928-25-000022
Chunk: 1

Company: Cresco Labs Inc.
Filing Date: 2025-08-20
Form: SC TO-I
Chunk 1
---
) to exchange (the “ Exchange Offer ”) certain outstanding options to purchase the Company’s subordinate voting shares for new restricted stock units (the “ New Awards ”). The Exchange Offer is being made upon the terms and subject to the conditions set forth in the Offer to Exchange Eligible Options for New Awards, dated August 20, 2025 (as it may be amended or supplemented from time to time, the “ Offer to Exchange ”), which is filed with this Schedule TO as Exhibit (a)(1)(A). The Exchange Offer will expire at 11:59 p.m., Eastern Time, on September 17, 2025, unless extended or earlier terminated (the “ Expiration Time ”). This Schedule TO is being filed in accordance with Rule 13e-4(c)(2) under the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”). The information contained in the Offer to Exchange is hereby expressly incorporated by reference in response to all items of this Schedule TO, and as more particularly set forth below.

## ITEM 1. Summary Term Sheet.
The information set forth in the Offer to Exchange under the heading “ Summary Term Sheet—Overview ” and “ Summary Term Sheet—Questions and Answers ” is incorporated herein by reference.

## ITEM 2. Subject Company Information.
(a) Name and Address . The name of the subject company, and the address and telephone number of its principal executive offices are as follows:

Cresco Labs Inc.
600 West Fulton Street, Suite 800
Chicago, IL 60661
(312) 929-0993

(b) Securities . This Schedule TO relates to certain outstanding options to purchase the Company’s subordinate voting shares. An option is eligible for exchange (an “ Eligible Option ”) if it is an outstanding option to purchase our subordinate voting shares that:

• is held by an Eligible Participant;

• is outstanding as of the Expiration Time;

• has an exercise price per share equal to or greater than $2.25 per share or an expiration date on or before September 30, 2030; and

• was granted under the Amended and Restated Cresco Labs Inc. 2018 Long-Term Incentive Plan.

As of August 19, 2025, there were options to purchase approximately 339,282,708 subordinate voting shares outstanding. As of August 19, 2025, there were Eligible Options to purchase 8,940,902 common shares outstanding.

The information set forth in